Evidence map›Paper›PMID 37614730›Full record

ArticleOpen veterinary journal2023

Sina Fereydooni, Farnoosh Arfaee, Mohammad Reza Youssefi, Fatemeh Zahra Gharib, Mohaddeseh Abouhosseini Tabari

Open access · goldAbstract read
In one paragraph

Article in Open veterinary journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sina FereydooniDepartment of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Farnoosh ArfaeeDepartment of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mohammad Reza YoussefiDepartment of Veterinary Parasitology, Babol Branch, Islamic Azad University, Babol, Iran.
Fatemeh Zahra GharibDepartment of Veterinary Clinical Sciences, Babol Branch, Islamic Azad University, Babol, Iran.
Mohaddeseh Abouhosseini TabariFaculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol, Iran.
Islamic Azad University, BabolIslamic Azad University, Science and Research Branch · IRAmol University of Special Modern Technologies · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Canine generalized demodicosis is an inflammatory skin disease, which usually has time-consuming and frustrating treatments. Aim: The present study aimed to evaluate the acaricidal activity of carvacrol as a green drug and a combination of carvacrol and amitraz on Methods: Mite samples were collected from a dog affected by demodicosis and had been diagnosed with deep skin scrapings. The motility of mites was examined by using optical microscopy. Samples were tested with 5% of carvacrol, the combination of Carvacrol 5% + Amitraz 0.05%, Amitraz 0.05% as a positive control, and mineral oil as a negative control. The interval time between the adding the test solutions and the moment the last mite ceased was defined as the survival time in the samples and the killing times of mites in each group were compared with each other. Results: It was determined that after administration of a 5% concentration of carvacrol, lethal effects were faster than the combination solution of Carvacrol 5% + Amitraz 0.05%, and the survival times in the control groups were longer than in both treatment groups. Conclusion: Carvacrol, as one of the most important bioactive terpenes, had the most effective

Indexed as

AcaricidesCanidaeAnimalsCymenesDogsToluidinesAcaricidesamitrazcarvacrolCymenesToluidinesAmitrazCanine demodicosisCarvacrolMiteSkin

Identifiers

PMID37614730
PMCPMC10443819
OpenAlexW4385445004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.